Back to dashboard
Medicare AdvantageAdministrativeMedium impact

We won’t require Medicare Advantage home infusion therapy providers to become Medicare-qualified HIT suppliers

BCBS Michigan·MI · Oncology, Infectious Disease, Gastroenterology +1 more·Pharmacy
Effective date
Not stated
We identified it
Jun 16, 2026
Days to comply

Summary

Blue Cross Blue Shield of Michigan has reversed its previously announced requirement that Medicare Advantage home infusion therapy providers must become Medicare-qualified HIT suppliers. Providers who were preparing for this enrollment requirement no longer need to complete it.

Action Required

Action needed
Immediately: Providers who offer home infusion therapy services can discontinue any efforts to become Medicare-qualified HIT suppliers for BCBSM Medicare Advantage plans. Update any internal compliance documentation to reflect this policy reversal. No new enrollment requirements are needed at this time.